These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 200697)

  • 21. Expression of mammary tumour virus in late-appearing mammary carcinomas in presumed virus-free mice.
    Bentvelzen P; Brinkhof J
    Eur J Cancer (1965); 1980 Feb; 16(2):267-71. PubMed ID: 6245888
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of spontaneous mammary tumorigenesis despite Mtv-1 gene expression in hybrid and backcross C3H-AvyfB X C3H/Sm mice.
    Smith GH; Henry TJ; Vlahakis G; Arthur LO
    Int J Cancer; 1982 May; 29(5):591-8. PubMed ID: 6284659
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative analysis of mouse mammary tumor virus in milk in two sublines of RIII/AnOk mice with low and high mammary tumor incidence.
    Takahashi M; Saga S; Nagayoshi S; Imai M; Tsutsui Y; Hoshino M
    Gan; 1983 Feb; 74(1):69-76. PubMed ID: 6301918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A congenic line of the DDD mouse strain, DDD/1-Mtv-2/Mtv-2: establishment and mammary tumorigenesis.
    Matsuzawa A; Sayama K; Tsubura A; Murakami A
    Jpn J Cancer Res; 1990; 81(6-7):639-44. PubMed ID: 1976120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mechanism of resistance to mouse mammary tumor virus infection.
    Golovkina TV
    J Virol; 2000 Mar; 74(6):2752-9. PubMed ID: 10684291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of energy restriction on mouse mammary tumor virus mRNA levels in mammary glands and uterus and on uterine endometrial hyperplasia and pituitary histology in C3H/SHN F1 mice.
    Koizumi A; Wada Y; Tsukada M; Kamiyama S; Weindruch R
    J Nutr; 1990 Nov; 120(11):1401-11. PubMed ID: 2172493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reinfection of virus free mice with mouse mammary tumour virus.
    Lee AE; Rogers LA; Topps S; Wallace K
    Lab Anim; 1989 Apr; 23(2):133-7. PubMed ID: 2540382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammary tumor virus antigen expression in inbred mouse strains of European origin established in Japan.
    Imai S; Morimoto J; Tsubura Y; Hilgers J
    Gan; 1980 Aug; 71(4):419-24. PubMed ID: 6253345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors.
    Michalides R; Wagenaar E; Nusse R
    J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analyses of differences in incidence of mammary tumors and reticulum cell neoplasms with the use of recombinant inbred lines of mice.
    Dux A; Mühlbock O; Bailey DW
    J Natl Cancer Inst; 1978 Oct; 61(4):1125-9. PubMed ID: 212568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammary tumorigenesis and tumor morphology in four C3H sublines with or without exogenous mammary tumor virus.
    Vaage J; Smith GH; Asch BB; Teramoto Y
    Cancer Res; 1986 Apr; 46(4 Pt 2):2096-100. PubMed ID: 2418961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conditions for hormone-stimulated expression of endogenous C57Bl strain-associated mammary tumor virus genome.
    Svec J; Hlavayová E; Matoska J; Thurzo V
    Neoplasma; 1979; 26(5):539-50. PubMed ID: 230421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Titrations of mammary tumor virus in fresh and treated R3 milk and milk fractions.
    Moore DH; Pillsbury N; Pullinger BD
    J Natl Cancer Inst; 1969 Dec; 43(6):1263-73. PubMed ID: 4319249
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of mammary tumors in C57BL/HAAG female mice by a low oncogenic mammary tumor virus.
    Vlahakis G; Chopra HC; Sawdon MR
    Int J Cancer; 1978 May; 21(5):648-51. PubMed ID: 207649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequences within the gag gene of mouse mammary tumor virus needed for mammary gland cell transformation.
    Swanson I; Jude BA; Zhang AR; Pucker A; Smith ZE; Golovkina TV
    J Virol; 2006 Apr; 80(7):3215-24. PubMed ID: 16537589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic mammary tumors in BALB/c mice.
    Moore DH; Sarkar NH; Holben JA; Sheffield JB
    Int J Cancer; 1979 May; 23(5):713-7. PubMed ID: 222695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the heterozygous nude gene with the asplenia trait in mammary tumorigenesis.
    Lopez DM; Pauley RJ; Lozzio BB
    J Exp Med; 1985 Mar; 161(3):629-34. PubMed ID: 2982992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models.
    Cremers N; Neeb A; Uhle T; Dimmler A; Rothley M; Allgayer H; Fodde R; Sleeman JP; Thiele W
    PLoS One; 2016; 11(3):e0151468. PubMed ID: 26978528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.